Differentiation of CD117+ Amniotic Fluid Stem Cells towards Nephron Progenitors

Hina Jabeen; Mohsin Wahid; Jahan Ara Ain Uddin; Farrukh Mustafa

doi:10.12669/pjms.38.6.4887

Differentiation of CD117⁺ Amniotic Fluid Stem Cells towards Nephron Progenitors

Pak J Med Sci. 2022 Jul-Aug;38(6):1656-1661. doi: 10.12669/pjms.38.6.4887.

Authors

Hina Jabeen¹, Mohsin Wahid², Jahan Ara Ain Uddin³, Farrukh Mustafa⁴

Affiliations

¹ Hina Jabeen Dow Research Institute of Biotechnology & Biomedical Sciences, & Department of Anatomy, Dr Ishrat ul Ebad Khan Institute of Oral Health Sciences, Dow University of Health Sciences, Karachi, Pakistan.
² Mohsin Wahid Dow Research Institute of Biotechnology & Biomedical Sciences & Department of Pathology, Dow International Medical College, Dow University of Health Sciences, Karachi, Pakistan.
³ Jahan Ara Ain Uddin Department of Gynecology & Obstetrics, Dow University Hospital, Dow University of Health Sciences, Karachi, Pakistan.
⁴ Farrukh Mustafa Department of Anatomy, Dow University of Health Sciences, Karachi, Pakistan.

Abstract

Objective: The study aimed at isolation of CD117⁺ stem cells from amniotic fluid samples followed by their invitro differentiation towards nephron progenitors that can be potentially used for regenerative medicine studies and to further understand pathways involved in renal pathogenesis.

Methods: This experimental study was conducted at Dow Research Institute of Biotechnology and Biomedical Sciences (DRIBBS), Dow University of Health Sciences, OJHA Campus Karachi from November 2019 to December 2020. After patient consent, a Pfannenstiel incision was performed by the gynecologist through abdominal and uterine muscles without cutting into Amniotic Membrane. Using a needle of 5CC syringe connected to sterile Redivac bottle, a blunt end insertion was passed through the membrane and the amniotic fluid was aseptically sucked into Redivac bottle, the ice bag was used for transporting amniotic fluid from hospital to the lab and samples were processed within 60 minutes after collection. Amniotic fluid was centrifuged at 4^º C for 20 minutes at 1400xg. After centrifugation the cell pellet was treated for analysis of CD117⁺ cells using flowcytometry, once small percentage of CD117⁺ cells were identified the cells were prepared for differentiation and that was carried out using specific growth factors including BMP4, BMP7, FGF2, and retinoic acid, providing the niche to the stem cells for differentiation towards nephron progenitors which was confirmed by protein expression of Wilms Tumor-1 (WT1) using immunofluorescence analysis. The sample size for this invitro work was n=3.

Results: We successfully isolated small percentage of CD117⁺ cells in amniotic fluid followed by in vitro expansion and differentiation towards nephron progenitor cells (NPCs) using well defined media and growth factors, initially differentiated cells were spindle shaped and showed fibroblastic appearance later at stage of nephron progenitors it attained the shape of rounded big clusters, differentiated cells stained positive for WT1 and negative for cluster of differentiation (CD117). Therefore, confirming the successful isolation and differentiation of amniotic fluid stem cells towards nephron progenitors.

Conclusion: To the best of our knowledge this is the first study from the country on the use of Amniotic fluid stem cells and their differentiation towards nephron progenitors that can be used as substitution source of cell therapy for exploration of renal diseases at cellular and molecular level and potential regenerative medicine applications.

Keywords: Amniotic fluid; Amniotic fluid stem cells (AFSCs); Nephron progenitors cells (NPCs); Regenerative medicine.